New cancer drug designed to overcome drug-resistant cells.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D004260:DNA Repair / Q000187:drug effects; D015195:Drug Design; D019008:Drug Resistance, Neoplasm; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006801:Humans; D009713:Nucleotidyltransferases / Q000037:antagonists & inhibitors
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D009713:Nucleotidyltransferases; C020658:glutamine-synthetase adenylyltransferase